Martha Floberg 2016-10-28 04:54:42
Advanced Technology and Treatment Benefit Patients It is no secret: Patti Beyer of Glenview will tell you in an instant that she feels fortunate to have Kellogg Cancer Center at her doorstep. Beyer is one of the first Chicago-area patients to take advantage of the latest tools for early diagnosis and treatment of breast cancer, especially for women with dense breast tissue. “Without NorthShore, I’d still have cancer today,” said Beyer, 64, who historically received normal results from her yearly mammograms. SUPERIOR SCREENING FOR DENSE TISSUE Earlier this year, in addition to her regular mammogram, Beyer took advantage of the latest technology now available at NorthShore: automated whole breast ultrasound (ABUS). The FDA-approved, noninvasive and radiation-free procedure is used in addition to traditional mammography. ABUS is proven to increase the accuracy of breast cancer screening in women with dense breast tissue. “My sister has the same type of dense breast tissue and told me I should have the ultrasound with my yearly mammogram,” Beyer noted. “Thankfully, I took her advice and my breast cancer was caught very early.” “In a short period of time, ABUS has proved to be an outstanding tool,” explained Catherine Pesce, MD, Director of NorthShore’s Surgical Breast Program. “It’s important for patients to know that NorthShore has this technology, as we’ve already identified quite a few patients with small breast tumors missed by mammograms,” added Radiologist Georgia Giakoumis Spear, MD, who specializes in breast imaging. Dr. Spear noted that nearly 70 percent of women in her practice have dense breast tissue. “Standard digital mammograms can miss one-third of breast cancers in this subset of patients because the overlapping tissue masks cancer.” Dr. Spear is leading research on ABUS as an additional screening tool. “Our studies will establish best-practice guidelines for physicians across the country.” MULTISPECIALTY COLLABORATION Drs. Pesce and Spear, who hold academic appointments at the University of Chicago Pritzker School of Medicine, worked together to develop a treatment plan for Beyer that included a lumpectomy to remove her tumor. The procedure involved another leading-edge technique called radioactive seed localization. Kellogg Cancer Center is one of a handful of providers in the area offering this advanced treatment option for breast cancer patients. Before surgery, a tiny radioactive seed is inserted in the area of the cancer. “This less-invasive procedure helps guide the surgeon to remove the tumor in an easier, more precise manner,” explained Dr. Pesce, a leader in the field. “Most importantly, the procedure increases the chances of getting all the cancer out in only one surgery.” Through this powerful combination of care, Beyer is now cancer-free and advocating for others. “Being on the other side of breast cancer, I encourage other women to find out whether they need the ABUS option,” said Beyer, who regularly uses the NorthShoreConnect app to communicate with her care team and set appointments via her smartphone. “I’m so grateful to Drs. Pesce and Spear and to NorthShore for offering advanced screening technologies for women.” EXPERT INSIGHTS ONLINE Does dense breast tissue increase your risk for cancer? Learn more about it on Healthy You, NorthShore’s online source for timely health and wellness news, at northshore.org/L10.
Published by Staywell/NorthShore University. View All Articles.
This page can be found at http://mydigimag.rrd.com/article/Breast+Cancer+Breakthrough/2621779/350929/article.html.